News & updates

AE-TBC wins EDCTP’s Outstanding Research Team 2020 prize!

Created on:

November 2, 2021

The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.

This prize is awarded to outstanding research teams in sub-Saharan Africa and Europe working on HIV/AIDS, tuberculosis, malaria and neglected infectious diseases (NID) in the scope of the EDCTP2 programme.

Professor Gerhard Walzl of AE-TBC upon accepting the EDCTP Outstanding Research Team prize: “I think the success of the AE-TBC shows that African institutions can lead international research effectively”

Check out the video here!

More news & updates

A Marie Skłodowska-Curie – Postdoctoral Fellowship in Leiden: success story by Prasanna Iyengar

June 21, 2021

In 2018, Prasanna Iyengar was awarded a Marie Skłodowska-Curie – Postdoctoral Fellowship (MSCA-IF) to implement a research project on bladder cancer at Leiden University Medical Center (LUMC) in The Netherlands. This two-year fellowship allowed Prasanna to pursue an independent line of research as a senior postdoc, thereby elucidating mechanisms of bladder cancer metastasis as well as further developing his career track.

An insight into the value of international collaborations in global health(care) challenges, to be further highlighted during Leiden2022

May 25, 2022

Leiden2022 marks what the City of Leiden has achieved in science till date and how it wishes to move forward to contribute to challenges of various kinds. The LUMC is one of many organizations showcasing science in practice with interactive events for a variety of target groups. Like with all Leiden based companies, Leiden2022 offers the LUMC the opportunity to show its societal and academic value on an international stage, strengthening its international position, as well as explore possibilities for new international collaborations to contribute to global healthcare challenges even more comprehensively. The Global Impact in Health symposium on May 30^th, 2022, part of the LSH week, aims to stimulate just that by bringing together healthcare experts from all over the world working on a broad range of important health(care) related research and projects. Here’s a few things you can expect.

LUMC Global is looking for a PhD Candidate/Physician-researcher Obstetrics

September 23, 2021

LUMC Global has set out to stimulate international connections in (bio)medical research and education to contribute to global healthcare. Setting up several PhD projects has been one of the key elements in doing this and we’re very proud we’ve been able to set up as many as eight different PhD projects. We are now looking for a Global PhD candidate in Obstetrics in a collaborative projects with Karolinska Institutet, Sweden and UZ Leuven, Belgium.